MetLife director awarded 273 shares in stock grant
MetLife, Inc. reported a director stock award.
Rhea-AI Filing Summary
MetLife, Inc. reported a director stock award. Non-management director Michelle Seitz acquired 273 shares of MetLife common stock on a grant basis, with a reported price of $0.00 per share.
After this award, she directly holds 273 common shares, reflecting compensation paid in stock under MetLife’s non-management director fee arrangements.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 273 shares
Grant/Award
1 txn
Insider
Seitz Michelle
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 273 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 273 shares (Direct)
Footnotes (1)
- F1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.
FAQ
What did MetLife (MET) director Michelle Seitz report on this Form 4?
Michelle Seitz reported the acquisition of 273 shares of MetLife common stock. The shares were received as a grant rather than an open-market purchase, and they represent part of her compensation as a non-management director paid in stock.
What is the nature of the MetLife (MET) stock transaction reported by Michelle Seitz?
The transaction is classified as a grant, award, or other acquisition of non-derivative common stock. Michelle Seitz received 273 shares directly, consistent with MetLife’s practice of paying a portion of non-management director retainer fees in company common stock.
How are MetLife (MET) non-management directors compensated according to this filing?
The footnote explains that MetLife’s non-management director compensation arrangements pay a portion of director retainer fees in MetLife common stock. The reported 273-share grant to Michelle Seitz reflects this equity-based component of her non-management director compensation.
AI-generated analysis. How Rhea-AI works. Not financial advice.